Form 4: Fulgent Genetics COO Sells Shares to Cover Tax Obligations

Fulgent Genetics' President and COO, Jian Xie, sold 1,455 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Summary

• Jian Xie, President and COO of Fulgent Genetics, sold 1,455 shares of common stock on December 3, 2024.
• The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted on February 28, 2022.
• The shares were sold at a weighted-average price of $19.4999, with individual transactions ranging from $19.46 to $19.58.
• Following the transaction, Mr. Xie directly owns 334,681 shares and indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment. It is a neutral event.

Industry Context

This is a routine transaction for company executives to manage their personal finances and tax obligations related to stock-based compensation. It is common for executives to sell shares to cover taxes when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The sale of 1,455 shares is relatively small compared to the total shares held by Mr. Xie, suggesting it is a routine transaction rather than a significant change in his investment position.
• Similar transactions are regularly reported by executives at comparable companies in the biotechnology and healthcare sectors.

Stakeholder Impact

• The sale is unlikely to have a significant impact on shareholders as it is a small transaction by an executive to cover tax obligations.

Key Dates

Keywords

Fulgent Genetics, FLGT, insider trading, stock sale, Jian Xie, restricted stock units, tax obligations, Form 4